We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
For manufacturers reporting adverse incidents with intraocular lenses under the vigilance system.
Form ST2: Statement of truth in support of an application based upon adverse possession of a rentcharge.
For manufacturers reporting adverse incidents with joint replacement implants under the vigilance system.
The alerting system provides an early warning when adverse temperatures are likely to impact on the health and wellbeing of the population.
A report covering adverse reactions to approved COVID-19 vaccines
Guidance on the use of Habitats Regulations Assessment
How a marketing authorisation holder should report a defect with a veterinary medicine.
For manufacturers reporting adverse incidents with biological/mechanical surgical heart valves under the vigilance system.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.